<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05055882</url>
  </required_header>
  <id_info>
    <org_study_id>CRC_GHN_2021_003</org_study_id>
    <nct_id>NCT05055882</nct_id>
  </id_info>
  <brief_title>Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and Adults</brief_title>
  <acronym>AURAL-STILL</acronym>
  <official_title>Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult-Onset Still's disease is a polygenic autoinflammatory disease of unknown etiology. The&#xD;
      autoinflammatory character individualizes it from autoimmune autoantibody diseases.&#xD;
      Clinically, it results in the classic triad associating hectic fever, evanescent rash and&#xD;
      arthritis. Although it is benign in the vast majority of cases, life-threatening&#xD;
      complications can occur. By definition, the disease affects adults over 16 years of age,&#xD;
      however most experts now agree that the adult form and the pediatric form belong to a&#xD;
      pathological continuum: Still's disease. In the absence of a specific biomarker, the&#xD;
      diagnosis is still based on clinical and biological criteria, after the exclusion of&#xD;
      differential diagnoses.&#xD;
&#xD;
      Classically, three evolutionary profiles of Adult-Onset Still's disease are individualized,&#xD;
      depending on the evolution of symptoms over time:&#xD;
&#xD;
        -  a monocyclic systemic form (30% of cases) characterized by clear systemic symptoms and&#xD;
           in the foreground compared to the articular signs. This form evolves over several weeks&#xD;
           to several months (on average 9 months), without exceeding a year. By definition, there&#xD;
           is no recurrence;&#xD;
&#xD;
        -  a polycyclic systemic form (30% of cases) defined by the occurrence of at least two&#xD;
           systemic or joint episodes, separated by clinical remission intervals greater than two&#xD;
           months, or even several years. The symptoms of relapses are not always the same as the&#xD;
           initial symptoms. The number and severity of relapses is unpredictable and varies widely&#xD;
           from patient to patient, but symptoms tend to become less severe over time.&#xD;
&#xD;
        -  a chronic form, with predominant joint involvement (40%), resembling seronegative&#xD;
           rheumatoid arthritis. Systemic signs are present during the first outbreaks of the&#xD;
           disease. Subsequently, rheumatoid arthritis evolves on its own and one can see joint&#xD;
           destruction or conversely ankylosing developments such as the classic bilateral,&#xD;
           non-erosive fusing carpitis.&#xD;
&#xD;
      There are reasons to believe that the evolving profile of patients has changed since the&#xD;
      emergence and generalization of biotherapies. Furthermore, no prognostic factor for the&#xD;
      progression of Adult-Onset Still's disease has been found so far. The differences between&#xD;
      pediatric and adult forms need to be confirmed and becoming pediatric forms in adulthood is&#xD;
      poorly described.&#xD;
&#xD;
      The objective of this study is to set up a regional research database&#xD;
      (Auvergne-Rhône-Alpes-Limousin) in order to describe the characteristics, treatment and&#xD;
      evolution of patients with Still's disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">February 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>validation of classification criteria</measure>
    <time_frame>at inclusion</time_frame>
    <description>number of participants with clinical and biological abnormalities, as assessed in the Yamaguchi and Fautrel criteria</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Still Disease</condition>
  <arm_group>
    <arm_group_label>children and adult diagnosed with Still's disease in Auvergne-Rhône-Alpes-Limousin hospital</arm_group_label>
    <description>children and adult with Still's disease in Auvergne-Rhône-Alpes-Limousin hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>children and adult with Still's disease in Auvergne-Rhône-Alpes-Limousin hospital</intervention_name>
    <description>Comparison of Adult-Onset Still's disease phenotypes</description>
    <arm_group_label>children and adult diagnosed with Still's disease in Auvergne-Rhône-Alpes-Limousin hospital</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        children and adult diagnosed with Still's disease in Auvergne-Rhône-Alpes-Limousin hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children and adult diagnosed with Still's disease in Auvergne-Rhône-Alpes-Limousin&#xD;
             hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not applicable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yvan Jamilloux, Dr</last_name>
    <phone>+33426732636</phone>
    <email>yvan.jamilloux@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier de Valence</name>
      <address>
        <city>Valence</city>
        <state>Drome</state>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Zenone, Dr</last_name>
      <phone>+33475757274</phone>
      <email>Thierry.zenone@chu-valence.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <state>Rhone Alpes</state>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvan Jamilloux, Dr</last_name>
      <phone>+33426732636</phone>
      <email>yvan.jamilloux@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Annecy</name>
      <address>
        <city>Annecy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Bérezné, Dr</last_name>
      <phone>+33450636363</phone>
      <email>alice.bérezné@chu-annecy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Bourg en Bresse</name>
      <address>
        <city>Bourg en Bresse</city>
        <zip>01012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Sève</last_name>
      <phone>+33426732636</phone>
      <email>pascal.seve@ch-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Bourgoin Jallieu</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <zip>38300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marielle Roux, Dr</last_name>
      <phone>+33469157329</phone>
      <email>marielle.roux@ch-bourgoin-jallieux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Chambéry</name>
      <address>
        <city>Chambéry</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Forestier, Dr</last_name>
      <phone>+33473965050</phone>
      <email>emmanuel.forestier@ch-chambery.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Châlon sur Saône</name>
      <address>
        <city>Châlon sur Saône</city>
        <zip>71321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Monard, Dr</last_name>
      <phone>+33385446688</phone>
      <email>eric.monard@ch-chalon-sur-saone.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Alpes-Léman (CHAL)</name>
      <address>
        <city>Contamine-sur-Arve</city>
        <zip>74130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Hubac, Dr</last_name>
      <phone>+33450823022</phone>
      <email>Jason.hubac@chal.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du puy en velay</name>
      <address>
        <city>Le Puy-en-Velay</city>
        <zip>43000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Planchette, Dr</last_name>
      <phone>+33471043463</phone>
      <email>julie.planchette@ch-lepuy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Liozon, Dr</last_name>
      <phone>+33555056990</phone>
      <email>eric.liozon@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Saint Luc Saint Joseph</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Martinon, Dr</last_name>
      <phone>+33478618329</phone>
      <email>smartinon@ch-stjoseph-stluc.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud Hot</last_name>
      <phone>+33472117565</phone>
      <email>arnaud.hot@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Montélimar</name>
      <address>
        <city>Montélimar</city>
        <zip>26200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Azzedine, Dr</last_name>
      <phone>+33475534429</phone>
      <email>ahmed.azzedine@ch-montelimar.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Vienne</name>
      <address>
        <city>Vienne</city>
        <zip>38200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leopold Adelaide, Dr</last_name>
      <phone>+33474313355</phone>
      <email>leopold.adelaide@ch-vienne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Villefranche</name>
      <address>
        <city>Villefranche-sur-Saône</city>
        <zip>69400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Le Scanff, Dr</last_name>
      <phone>+33474092929</phone>
      <email>julie.le-scanff@ch-nordouest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Médipôle de Villeurbanne</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand Issartel, Dr</last_name>
      <phone>+33472823400</phone>
      <email>Bertrand.issartel@medipole.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The individual participant data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

